UBS analyst Karl Keirstead maintains MongoDB (NASDAQ:MDB) with a Buy and raises the price target from $200 to $215.
Piper Sandler Maintains Neutral on Pacific Biosciences, Raises Price Target to $7.5
Piper Sandler analyst David Westenberg maintains Pacific Biosciences (NASDAQ:PACB) with a Neutral and raises the price target from $6 to $7.5.